TransMedics Group, Inc. ( TMDX) - Stock Earnings
TMDX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
TMDX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 105.4 million USD | 160.8 million USD |
| 2026Q1 | 7.3 million USD | 173.9 million USD |
| 2026Q2 | 14.7 million USD | 189.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TMDX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -25.0 million USD | 241.6 million USD |
| 2024 | 35.5 million USD | 441.5 million USD |
| 2025 | 190.3 million USD | 605.5 million USD |
| 2026 Est. | — | — |
TMDX
Price: $77.87
Earnings Per Share: 4.07 USD
P/E Ratio: 21.72
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 513900
Market Capitalization: 2.9 billion